Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.
| SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH IRELAND LTD. and ALFASIGMA S.P.A. |
| NORWICH PHARMACEUTICALS INC. |
| 23-1952 |
| May 30, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 13, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Note to File: The following cases are consolidated: 22-2153 Lead with 23-1952 Cross-Appeal. The parties must file all documents in the lead appeal only. [929730] [22-2153, 23-1952] [KMH] [Entered: 06/13/2023 02:39 PM] |
| Filing 9 Notice of Related Case Information for Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929504] [23-1952] [William Peterson] [Entered: 06/13/2023 09:50 AM] |
| Filing 8 Certificate of Interest for Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929502] [23-1952] [William Peterson] [Entered: 06/13/2023 09:49 AM] |
| Filing 7 Docketing Statement for the Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929497] [23-1952] [William Peterson] [Entered: 06/13/2023 09:47 AM] |
| Filing 6 Entry of Appearance for William R. Peterson; Michael J. Abernathy; Julie S. Goldemberg; Michael T. Sikora; Karon N. Fowler as counsel for Appellees Bausch Health Ireland Ltd., Alfasigma S.p.A., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929495] [23-1952] [William Peterson] [Entered: 06/13/2023 09:45 AM] |
| Filing 5 Notice of Related Case Information for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928507] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:55 PM] |
| Filing 4 Docketing Statement for the Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928506] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:54 PM] |
| Filing 3 Certificate of Interest for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928505] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:53 PM] |
| Filing 2 Entry of Appearance for Chad Landmon; Matthew Murphy; Thomas Hedemann; Matthew Becker as counsel for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928503] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:52 PM] |
| Filing 1 Appeal docketed. Received: 05/22/2023. [926423] Entry of Appearance due 06/13/2023. Certificate of Interest is due on 06/13/2023. Docketing Statement due 06/13/2023. Appellant/Petitioner's brief is due 07/31/2023. [KMH] [Entered: 05/30/2023 10:53 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
